The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: tenofovir     Quarter: 2016Q3

Total Records: 439     Number of Pages: 22

DRUGNAME PT EventCount
TENOFOVIR DISOPROXIL FUMARATE. Foetal exposure during pregnancy 9
TENOFOVIR DISOPROXIL FUMARATE. Viral load increased 9
Tenofovir Abortion spontaneous 8
Tenofovir Virologic failure 8
TENOFOVIR DISOPROXIL FUMARATE. Gamma-glutamyltransferase increased 8
TENOFOVIR DISOPROXIL FUMARATE. Osteoporosis 8
TENOFOVIR DISOPROXIL FUMARATE. Vomiting 8
TENOFOVIR Foetal death 7
TENOFOVIR DISOPROXIL FUMARATE. Chronic kidney disease 7
TENOFOVIR DISOPROXIL FUMARATE. Diabetes mellitus 7
TENOFOVIR DISOPROXIL FUMARATE. Fanconi syndrome acquired 7
TENOFOVIR DISOPROXIL FUMARATE. Foot fracture 7
TENOFOVIR DISOPROXIL FUMARATE. Hepatic enzyme abnormal 7
Tenofovir/Emtricitabine Premature baby 7
TENOFOVIR Premature baby 6
Tenofovir Viral load increased 6
TENOFOVIR DISOPROXIL FUMARATE. Caesarean section 6
TENOFOVIR DISOPROXIL FUMARATE. Cholecystitis acute 6
TENOFOVIR DISOPROXIL FUMARATE. Normal newborn 6
TENOFOVIR DISOPROXIL FUMARATE. Pathogen resistance 6

Total Records: 439     Number of Pages: 22